You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(600196.SH)控股子公司重慶藥友通過GMP認證檢查
格隆匯 12-26 17:15

格隆匯12月26日丨復星醫藥(600196.SH)公佈,公司控股子公司重慶藥友製藥有限責任公司收到重慶市藥品監督管理局頒發的《關於藥品生產企業GMP認證檢查結果的通知》。

公告顯示,認證範圍包括1、口服固體制劑生產線II(片劑、硬膠囊劑、散劑),原料藥(阿法骨化醇、甲磺酸瑞波西汀、鹽酸納洛酮、右泛醇、四水合輔羧酶),無菌原料藥(賴氨匹林);2、303車間1線(硬膠囊劑)。

據悉,本次通過GMP檢查的生產設施為重慶藥友人和廠區的口服固體制劑生產線II、原料藥生產線、無菌原料藥生產線,及水土廠區的303車間1線;本次認證2累計投入人民幣約3,875萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account